Jane Grogan - Principal Scientist, Cancer Immunology

Jane Grogan

Principal Scientist, Cancer Immunology

Postdoc Mentor
13
Years at Genentech
28
Publications
1
Awards & Honors

I joined Genentech in 2004 as a scientist in the research immunology group. My background has ranged from exploring anti-helminthic responses in patients as a PhD student in Leiden, The Netherlands, to identifying novel surface markers on effector T cells at the DRFZ in Berlin, to exploring chromatin remodeling of cytokine genes in effector T cells during my post-doc at UCSF. I joined Genentech because it gave me the opportunity to apply my knowledge of both the human and murine immune response to understanding the pathogenesis of debilitating human autoimmune and inflammatory diseases. I’m at Genentech because of the scientific rigor, the great colleagues, the support and the commitment we all have to making transformative medicines.

Featured Publication

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function.

Cancer Cell, 2014, 26:923-37.

Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, Park S, Javinal V, Chiu H, Irving B, Eaton DL, Grogan JL.